clinical trial · NCT07616375
A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Haisco Pharmaceutical Group Co., Ltd.·phase3·recruiting·n = 669
Non-cystic Fibrosis BronchiectasisHSK31858, tablet
brief summary
This is a phase III, single-arm, open-label, multicenter study to assess the safety of HSK31858 in non-cystic fibrosis bronchiectasis (NCFBE) participants.
started
Sep 28, 2025
primary completion
Jan 10, 2029
completion
Apr 3, 2029
last updated
Jun 1, 2026
official title
Phase 3 Single-arm, Open-label, Multicenter Study to Assess the Safety of HSK31858 in Participants With Non-cystic Fibrosis Bronchiectasis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol